Search alternatives:
elective » effective (Expand Search), executive (Expand Search)
selective » seffective (Expand Search), sexecutive (Expand Search), selection (Expand Search)
elective » effective (Expand Search), executive (Expand Search)
selective » seffective (Expand Search), sexecutive (Expand Search), selection (Expand Search)
-
41
Comparative analysis of hybrid-SNP microarray and nanopore sequencing for detection of large-sized copy number variants in the human genome
Published 2025-07-01“…In this work, we used nanopore sequencing technology to sequence 2 human cell lines at low depth of coverage to call copy number variations (CNV), and compared the results variant by variant with chromosomal microarray (CMA) results. Results We analysed sequencing data using CuteSV and Sniffles2 variant callers, compared breakpoints based on hybrid-SNP microarray, nanopore sequencing and Sanger sequencing, and analysed CNV coverage. …”
Get full text
Article -
42
-
43
Robust molecular subgrouping and reference-free aneuploidy detection in medulloblastoma using low-depth whole genome bisulfite sequencing
Published 2025-06-01“…We further assessed and optimised reference-free aneuploidy detection using low-pass WGBS and assessed concordance with microarray-derived calls. …”
Get full text
Article -
44
Whole genome uniparental isodisomy detected using single nucleotide polymorphism (SNP) microarray in molar pregnancy: a case report
Published 2025-02-01“…High-resolution SNP microarray studies detected whole genome uniparental isodisomy. …”
Get full text
Article -
45
Expression of long non-coding RNA in patients with non-IgA mesangial proliferative glomerulonephritis
Published 2015-01-01“…Objective To study differential expression profile of mRNA and long non-coding RNA(IncRNA) through microarray analysis between non-IgA mesangial proliferative glomerulonephritis(MsPGN) patients and the controls,and then explore the potential role of IncRNA in the pathogenesis of non-IgA MsPGN.Methods Through simple random sampling,4 patients with non-IgA MsPGN and 2 controls were selected as disease group and control group,respectively.Renal cortical tissues from two groups were collected.Total RNA was extracted,quantified and prepared to ds-cDNA through reverse transcription ds-cDNA was labeled with NimbleGen one-color DNA labeling kit and used for array hybridization.All experimental data were processed through GO analysis,Pathway analysis and the gene loci correlation analysis of mRNA and IncRNA.Some IncRNAs that were closely related to non-IgA MsPGN were screened out.Finally,part of the array results was detected by PCR to verify the reliability of array test Results By fold change filtering,4317 differentially expressed mRNAs and 3502 differentially expressed IncRNAs were screened out.Five IncRNAs were found to play potential roles in the pathogenesis of non-IgA MsPGN:AF1180924(close to coding gene FGG),AK092233(close to coding gene COL18A1),AK130579(close to coding gene CREBBP),AK023598(close to coding gene LEPR),and AK055915(close to coding gene CDC42EP3).These results provided an important basis for revealing the pathogenesis of non-IgA MsPGN.Conclusions Some IncRNAs can potentially regulate related genes and plays an important role in the pathogenesis and development of non-IgA MsPGN.…”
Get full text
Article -
46
Gene selection based on adaptive neighborhood-preserving multi-objective particle swarm optimization
Published 2025-05-01Subjects: “…Microarray gene selection…”
Get full text
Article -
47
Optimized T7 Amplification System for Microarray Analysis
Published 2001-10-01“…Glass cDNA microarray technologies offer a highly parallel approach for profiling expressed gene sequences in disease-relevant tissues. …”
Get full text
Article -
48
A two stage grading approach for feature selection and classification of microarray data using Pareto based feature ranking techniques: A case study
Published 2020-02-01“…High dimensional search space in microarray data with large number of genes and few dozen of samples increases the complexity of analysis of such databases. …”
Get full text
Article -
49
Evaluating the Nuclear Reaction Optimization (NRO) Algorithm for Gene Selection in Cancer Classification
Published 2025-04-01Subjects: Get full text
Article -
50
Analysis of a Series of 26 Cases With Prenatal Skeletal Dysplasia via Multiplatform Genetic Detection
Published 2025-01-01“…Materials and Methods In this study, we recruited 26 cases of SD and analyzed them with a designed sequential genetic detection. Chromosome karyotyping, microarray analysis (CMA), and whole exome sequencing (WES) techniques are performed as needed. …”
Get full text
Article -
51
-
52
Fast Spot Locating for Low-Density DNA Microarray
Published 2025-03-01“…Low-density DNA microarrays are crucial in molecular diagnostics due to their cost-effectiveness and high sensitivity. …”
Get full text
Article -
53
Microarray-Based Cancer Diagnosis with Artificial Neural Networks
Published 2003-03-01Get full text
Article -
54
Fabrication of DNA Microarrays Using Unmodified Oligonucleotide Probes
Published 2001-02-01“…Microarrays printed on glass slides are often constructed by covalently linking oligonucleotide probes to a derivatized surface. …”
Get full text
Article -
55
Listen to genes: dealing with microarray data in the frequency domain.
Published 2009-01-01“…<h4>Background</h4>We present a novel and systematic approach to analyze temporal microarray data. The approach includes normalization, clustering and network analysis of genes.…”
Get full text
Article -
56
-
57
-
58
A Sensitive and Fast microRNA Detection Platform Based on CRlSPR-Cas12a Coupled with Hybridization Chain Reaction and Photonic Crystal Microarray
Published 2025-04-01“…The sensitive and fast detection of miRNAs is critical for diagnosis and prognosis. …”
Get full text
Article -
59
Application of chromosome microarray analysis and karyotyping in fetal cardiac abnormalities
Published 2025-06-01“…Chromosome microarray analysis detected abnormalities in 6.58% (5/76) of the isolated cardiac abnormalities group and 27.27% (6/22) in the group with combined abnormalities, showing a significant statistical difference (P < 0.05). …”
Get full text
Article -
60